Fosun International Issues 1H2026 Positive Profit Alert as Core Industries Show Strong ResilienceAsian Corporate Newswire·21 hours ago00656-0.63%02196-0.30%
Hengrui Pharma Wins First China Approval for Home-Grown Long-Acting Insulin AnalogTip Ranks·2 days ago, 09:38 AM01276-0.52%600276-1.04%
Fosun expects 1H profit attributable to owners at RMB 1.5 billion-RMB 1.8 billionPUBT·2 days ago, 04:33 AM02196-0.30%00656-0.63%
From confidence to capital: Positioning biotech for the next growth cyclebiopharmadive·Jul 27 at 10:38 AMLABU-8.60%LABD+8.48%
Nomura Cuts HENGRUI PHARMA TP to HKD82.18, Lowers FY2026 Revenue and Profit ForecastsAASTOCKS News·Jul 26 at 10:29 PM01276-0.52%600276-1.04%
Chinese biotech overtakes AI as emerging-market growth tradeBusinesstimes News·Jul 26 at 10:14 PM300765+5.61%AZN-0.99%
As weight-loss drug orders surge, global funds pile into China’s WuXi AppTecSCMP·Jul 24 at 05:39 AM02359+1.90%603259+2.35%
10:30 ETSingle-use Bioreactors Market worth $9.58 billion by 2031 - Exclusive Report by MarketsandMarkets™prnewswire·Jul 23 at 09:31 AMLABD+8.48%IBBQ-1.83%
Hengrui Wins NMPA Nod to Move Cervical Cancer Combo to First-Line UseTip Ranks·Jul 23 at 07:37 AM01276-0.52%600276-1.04%
Hengrui Pharma wins China approval for camrelizumab-famitinib combo as 1L cervical cancer treatmentPUBT·Jul 23 at 07:32 AM01276-0.52%600276-1.04%
WuXi AppTec joins FTSE4Good Index Series for fourth straight yearPUBT·Jul 21 at 06:54 PM02359+1.90%603259+2.35%
China's Humanoid Robot Products Exceed 400 Models, Accounting for Over Half of Global TotalAASTOCKS News·Jul 20 at 01:00 AM513060+0.38%159859+1.32%
China's 1H25 Innovative Drug Out-Licensing Deal Value Exceeds USD100 Billion, Hitting New HighAASTOCKS News·Jul 20 at 01:00 AM510660+0.86%159992+1.57%
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Receives a Buy from Morgan StanleyTip Ranks·Jul 17 at 07:27 PM01276-0.52%600276-1.04%
IDEAYA shares ESMO 2026 data updates for darovasertib trials in uveal melanomaPUBT·Jul 17 at 08:00 AMIDYA-2.47%01276-0.52%
